| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/17/2006 | WO2005034858A3 Compositions and methods for treatment of muscle pain and muscle wasting |
| 08/17/2006 | WO2005017177A3 Modulators of nod1 signaling |
| 08/17/2006 | WO2004094647A3 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 08/17/2006 | WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/17/2006 | WO2003082203A3 Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
| 08/17/2006 | WO2003066831A3 Angiogenesis genes |
| 08/17/2006 | WO2003062391A3 Structural and cytoskeleton-associated proteins |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060185026 Atypical protein kinase c isoforms in disorders of the nervous system and cancer |
| 08/17/2006 | US20060183920 more especially its tert-butylamine salt; synthesis intermediates; carried out in the presence of an activation reagent selected from N-methyl-N-phenyl-aminotriphenylphosphonium iodide and hexamethylphosphorus triamide together with ammonium perchlorate by Mitsunobu reaction |
| 08/17/2006 | US20060183891 Delta 4,5 glycuronidase nucleic acid compositions |
| 08/17/2006 | US20060183887 Human monoclonal antibodies to epidermal growth factor receptor |
| 08/17/2006 | US20060183884 Compounds and methods for modulating cell adhesion |
| 08/17/2006 | US20060183883 C5a Receptor antagonists |
| 08/17/2006 | US20060183798 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183778 Osteogenesis-promotion enhancer and method of screening the same |
| 08/17/2006 | US20060183744 Method for treating depression and/or anxiety |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060183708 Topical Delivery of Trace Metals for Enzyme Modulation |
| 08/17/2006 | US20060183705 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183699 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183694 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid |
| 08/17/2006 | US20060183693 Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine |
| 08/17/2006 | US20060183692 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 08/17/2006 | US20060183691 Anti-hypertensive molecules and process for preparation thereof |
| 08/17/2006 | US20060183690 Fish protein hydrolysates (Salmo or Oncorhynchus); for inhibiting angiotensin converting enzyme |
| 08/17/2006 | US20060183689 Activation of peptide prodrugs by hK2 |
| 08/17/2006 | US20060183688 Screening for drugs for treatment of pathologies involving deregulation of apoptosis including autoimmune diseases, neurological disorders and cancers |
| 08/17/2006 | US20060183687 Novel therapeutic molecules |
| 08/17/2006 | US20060183686 Thrombin-activatable fibrinolysis inhibitors (TAFI) enzyme molecules; inhibit the breakdown of blood clots, for use in treatment of blood disorders wherein clotting needs to be regulated or promoted, such as hemophilia or von Willebrand's disease |
| 08/17/2006 | US20060183685 Peptide pharmaceutical formulations |
| 08/17/2006 | US20060183684 For treating a disease or condition related to angiogenesis |
| 08/17/2006 | US20060183683 Liquid composition of factor VII polypeptides |
| 08/17/2006 | US20060183682 Stabilized pharmaceutical peptide compositions |
| 08/17/2006 | US20060183681 Stabilized compositions containing natriuretic peptides |
| 08/17/2006 | US20060183680 Remedy for ischemia |
| 08/17/2006 | US20060183679 Peptides having a high cysteine content |
| 08/17/2006 | US20060183678 Nogo a binding molecules and pharmaceutical use thereof |
| 08/17/2006 | US20060183677 Novel exendin agonist formulations and methods of administration thereof |
| 08/17/2006 | US20060183676 Treatment of mycobacterium tuberculosis with antisense oligonucleotides |
| 08/17/2006 | US20060183675 Controlling microorganisms; wound healing products, bandages, medical devices such as, e.g., catheters and further in anti-dandruff hair products |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183673 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/17/2006 | US20060183672 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma |
| 08/17/2006 | US20060183671 Treatment of anemia |
| 08/17/2006 | US20060183670 Autoantigen composition |
| 08/17/2006 | US20060183669 separating two forms of a polypeptide having a single amino acid racemization by eluting the two forms of the polypeptide from an ion exchange chromatography resin under conditions where the salt concentration is increased at a pH that is no more than 1 pH unit from a pKa of X |
| 08/17/2006 | US20060183668 Novel insulin derivatives |
| 08/17/2006 | US20060183667 Stabilised insulin compositions |
| 08/17/2006 | US20060183666 Method of purifying preproinsulin |
| 08/17/2006 | US20060183665 Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183207 Derived from Pyrococcus furious; structure-specific cleavage agents and polymerases for the cleavage and modification of nucleic acids |
| 08/17/2006 | US20060183196 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof |
| 08/17/2006 | US20060183194 Heregulin variants |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183191 Synthetic approach to designed chemical structures |
| 08/17/2006 | US20060183186 Gene expression profiles in stomach cancer |
| 08/17/2006 | US20060183180 Viewing attention deficit disorder as protein degradation defect and treat via trypsin, protease, chymotrypsin and/or pancreatic enzyme digestion |
| 08/17/2006 | US20060183164 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 08/17/2006 | US20060183160 Novel beta-secretase and modulation of beta-secretase activity |
| 08/17/2006 | US20060183158 Novel gene and use thereof |
| 08/17/2006 | US20060183156 PrPSc-selective peptides |
| 08/17/2006 | US20060183130 Methods for assessing p19-Arf interactions with cMyc |
| 08/17/2006 | US20060183114 Novel Eosinophil Cationic Proteins used in the Treatement of Asthematic and Allergic Disorders |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182809 System for transporting active substances in a biological system |
| 08/17/2006 | US20060182807 Copolymer and hemoprotein based novel compounds and uses thereof |
| 08/17/2006 | US20060182795 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders |
| 08/17/2006 | US20060182794 Stabilized compositions for topical administration and methods of making same |
| 08/17/2006 | US20060182792 Liposome-forming compositions |
| 08/17/2006 | US20060182789 Apparatus and method for transdermal delivery of epoetin-based agents |
| 08/17/2006 | US20060182784 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 08/17/2006 | US20060182764 Enhancing the effect of vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 08/17/2006 | US20060182761 Methionine salvage pathway in Bacillus |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | US20060182746 Binding to monoclonal antibody; antitumor agents |
| 08/17/2006 | US20060182739 By ion exchange chromatography and involves changing the conductivity and/or pH of buffers in order to resolve the polypeptide of interest |
| 08/17/2006 | US20060182737 Wet wipes including a composition for reduction and prevention of wrinkles on the skin |
| 08/17/2006 | US20060182736 Transducible dna-binding proteins |
| 08/17/2006 | US20060182735 Thrombin preparations and process for their production |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for |
| 08/17/2006 | US20060182732 Composition for mitigating a pernicious thrombotic event |
| 08/17/2006 | US20060182731 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 08/17/2006 | US20060182730 Antiobesity agent using hen's egg antibody against digestive enzymes |
| 08/17/2006 | US20060182729 Combat/training antioxidant micronutrient formulation and method of administration |
| 08/17/2006 | US20060182728 Viewing attention deficit disorder as protein degradation defect and treat via trypsin, protease, chymotrypsin and/or pancreatic enzyme digestion |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182716 Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same |
| 08/17/2006 | US20060182715 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-ss |
| 08/17/2006 | US20060182714 Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides |
| 08/17/2006 | US20060182713 Vaccine composition comprising interleukin-15 (il-15) |
| 08/17/2006 | US20060182712 CCR ligands for stem cell homing |